Fig. 4From: Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitusChoropleth map of cardiovascular mortality. The map reveals that regional difference of cardiovascular mortality in Israel, Netherlands, UK, and USA. Metformin treatment has no meaningful impact on cardiovascular mortality versus control, in each countryBack to article page